+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Eczema Drug"

From
From
From
Atopic Dermatitis Drugs - Global Strategic Business Report - Product Thumbnail Image

Atopic Dermatitis Drugs - Global Strategic Business Report

  • Report
  • April 2025
  • 179 Pages
  • Global
From
From
Atopic Dermatitis - Pipeline Insight, 2025 - Product Thumbnail Image

Atopic Dermatitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 280 Pages
  • Global
From
Seborrheic Eczema - Pipeline Insight, 2025 - Product Thumbnail Image

Seborrheic Eczema - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Eczema- Pipeline Insight, 2025 - Product Thumbnail Image

Eczema- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 250 Pages
  • Global
From
From
Atopic Dermatitis Drugs Market 2024-2028 - Product Thumbnail Image

Atopic Dermatitis Drugs Market 2024-2028

  • Report
  • May 2024
  • 175 Pages
  • Global
From
From
From
Moderate To Severe Atopic Dermatitis - Pipeline Insight, 2025 - Product Thumbnail Image

Moderate To Severe Atopic Dermatitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Chronic Hand Eczema - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Hand Eczema - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
From
From
From
Loading Indicator

The Eczema Drug market is a subset of the Dermatological Drugs market, which includes medications used to treat skin conditions. Eczema drugs are used to treat the symptoms of eczema, a chronic skin condition characterized by red, itchy, and inflamed skin. These drugs are typically topical creams, ointments, and lotions, and may contain corticosteroids, calcineurin inhibitors, and other active ingredients. In addition to treating the symptoms of eczema, these drugs may also help to reduce the risk of infection and improve the overall quality of life for those affected by the condition. Some companies in the Eczema Drug market include GlaxoSmithKline, Pfizer, Novartis, Sanofi, and Mylan. Show Less Read more